Two more applications joined mHealthBelgium – Healthentia and Sunrise

05

Aug 2020

In July 2020, two new apps entered the level 1 of the mHealthBelgium validation pyramid.

The Healthentia key features:

  • Can be used by
    • patients – subjects to a clinical study
    • investigators of clinical studies
    • healthy individuals
  • The primary function is to support the capturing of data in clinical studies
  • Individuals can report and monitor their outcomes (e.g., symptoms) and activity and receive automatic-generated questionnaires for wellbeing. Aggregated data provided after users’ consent, can be processed for conducting non-profit research studies
  • In sponsored clinical trials the app can be used to carry out study protocols
  • The mobile application can be paired with wearable devices (e.g., activity trackers), as well as other medical devices and sensors.
  • It is planned to add eHealth services to the users in next versions of Healthentia
  • The application is free-of-charge for individuals, while for sponsor organizations, there is a fee per user per month in PaaS or SaaS model.

The Sunrise key features:

  • Sunrise is a medical device (Class IIa) that includes a mobile application, a sensor to be placed on the chin and a web platform for healthcare professionals
  • The sensor placed on the chin records the mandibular movements
  • The app analyzes the data gathered by the sensor from a secured cloud in real-time using artificial intelligence
  • Clinical tests carried out on 400 patients show a 90% agreement with polysomnography for the diagnosis of obstructive sleep apnea
  • It is approved for both adults and children
  • Pricing information can be obtained by request on the manufacturer’s website

See the full details on Healthentia here, and on Sunrise here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

17

Mar 2022

On February 21, 2022, it was announced by the Ministry of Health that the public consultation regarding the Draft Order amending the Common Package of Benefits of the National Health System (SNS) was open. The amendments and clarifications are related to the fields of in-vitro diagnostics, ENT, pulmonary and airways, e-health, neurology, dental care, radiology, and enteral nutrition.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

10

Mar 2022

In February 2022, the Finnish Coordinating Center for Health Technology Assessment announced the release of the seven accomplished rapid hospital assessments performed by the Helsinki, Tampere, and Oulu University Hospital. The accomplished rapid HTAs concern the diagnostic imaging, e-Health, endocrine, endoscopy, men’s health, neuromodulation technology groups.

Read more

03

Mar 2022

In February 2022, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, thirty health apps are now available at the DiGA Directory.

Read more